The focus of the presentation will be on the subgroup of patients who have received 100mg bezuclastinib for at least 48 weeks to highlight the symptomatic benefits of long-term use.

The Penn Center for Innovation has enabled world-changing advancements, from mRNA vaccines to CAR T cancer treatments.

Sam Finn, a senior research associate at Zymo Research working with the Oncology Diagnostic Team, helped to host this interactive game booth at the “BioFestival” on Tuesday.

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent loss disorders, today announces ...

IgGenix, Inc., a clinical-stage biotechnology company pioneering innovative treatments for immune-mediated diseases, today announced the upcoming presentation of new data at the 2025 American Academy ...

Thank you for standing by, and welcome to the Origin Agritech Fiscal Year 2024 Conference Call. Please note that, today's call is being recorded. It is now my pleasure to introduce Matthew Abenante of ...

A biohybrid hand which can move objects and do a scissor gesture has been built by a team at the University of Tokyo and ...

Kier considers all Lumon employees his “children.” But if you’re a Severance fan, it’s best to know his actual children, too.

By sharing the stories of EDI champions in science, we hope to shed light on both the importance of diversity and the ...

In a significant reaffirmation of their partnership, Prime Minister Narendra Modi and US President Donald Trump highlighted ...